<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220529055009N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-02-05</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of Rivandi Syrup on Non-Alcoholic Fatty Liver</public_title>
      <acronym></acronym>
      <scientific_title>To Evaluate the Efficacy of Rivandi Syrup on Non-Alcoholic Fatty Liver Patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-08-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/63966</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: At first, a block of 4 (A-B-C-D) is created, and bottles of drugs or placebos have one of these four labels. In it, there are two letters of drug and two letters of placebo (for example, A and D for drug and B and C for placebo).
 According to the order of the patients' referral to the plan and after obtaining written consent, the patient will be placed in one of the 4 groups randomly (lottery), and after 4 patients enter the RCT and the end of the 4-pack, another 4-pack will be opened for the 5th to 8th patients. can be Medicines labeled A to D are delivered to Salamat Kedeh pharmacy and the patient receives the medicine with that label after drawing a lottery and getting the letter A, B, C, or D, Blinding description: Bottles of drugs with labels A to D are made by the pharmacist and delivered to the Salamat Kode pharmacy, which two labels are drug and two are placebos, and the pharmacist only knows the contents of each bottle. Patients receives that label and until the end of the RCT (3 Months), it is delivered to him with all the initial labels.</study_design>
      <phase>3</phase>
      <hc_freetext>Non Alcoholic Fatty Liver.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: rhubarb syrup is prepared in the pharmacy laboratory of the Faculty of Traditional Medicine of Tehran University of Medical Sciences (Jalinian medicine) with the combination of  Chinese rhubarb, Fumitory and Dodder, whose herbarium code is obtained from the Faculty of Pharmacy of the university, and in 250 bottles CC is provided to patients. Consuming it as one tablespoon three times a day (breakfast, before lunch and before bed). Intervention 2: Control group: Placebo syrup is prepared in the pharmaceutical laboratory of the Faculty of Traditional Medicine of Tehran University of Medical Sciences and is available to patients in 250 cc bottles. Consuming it as one tablespoon three times a day (before breakfast, before lunch and before bed).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is N/A</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hossein Rezaeizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No27- North Sarparast St- Felestin Sq</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>2188974535</zip>
        <telephone>+98 21 8897 4535</telephone>
        <email>rezaeizadeh@sina.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hossein Rezaeizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No27- North Sarparast- Felestin Sq</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>2188974535</zip>
        <telephone>+98 21 8897 4535</telephone>
        <email>rezaeizadeh@sina.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Non Alcoholic Fatty Liver Patients</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Diabetes, Hypertension, Familial Hyper Lipedema, Chronic Heart Disease
Alcohol Use
Pregnancy, Lactation</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K76.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Fatty (change of) liver, not elsewhere classified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: rhubarb syrup is prepared in the pharmacy laboratory of the Faculty of Traditional Medicine of Tehran University of Medical Sciences (Jalinian medicine) with the combination of  Chinese rhubarb, Fumitory and Dodder, whose herbarium code is obtained from the Faculty of Pharmacy of the university, and in 250 bottles CC is provided to patients. Consuming it as one tablespoon three times a day (breakfast, before lunch and before bed)</i_keyword>
      <i_keyword>Control group: Placebo syrup is prepared in the pharmaceutical laboratory of the Faculty of Traditional Medicine of Tehran University of Medical Sciences and is available to patients in 250 cc bottles. Consuming it as one tablespoon three times a day (before breakfast, before lunch and before bed)</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>CAP (Controlled Attenuation Parameter) Index in Fibroscan. Timepoint: 0 and 3 Months. Method of measurement: Fibroscan Device.</prim_outcome>
      <prim_outcome>LSM (Liver Stiffness Measurement) in Fibroscan. Timepoint: 0 and 3 Months. Method of measurement: Fibroscan Device.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Blood Serum Aspartate Transferase (AST). Timepoint: 0 and 3th months. Method of measurement: Blood Test.</sec_outcome>
      <sec_outcome>Blood Test Alanine aminotransferase (ALT). Timepoint: 0 and 3th months. Method of measurement: Laboratory Blood Test.</sec_outcome>
      <sec_outcome>Blood Test Alkaline phosphatase (ALP). Timepoint: 0 and 3th months. Method of measurement: Laboratory Blood Test.</sec_outcome>
      <sec_outcome>Body Mass Index (BMI)= ratio of person's weight in kilograms and height in metres squared. Timepoint: 0 and 3th months. Method of measurement: Standard Scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-05-23</approval_date>
        <contact_name>Ethics committee of Tehran University of Medical Sciences (TUMS)</contact_name>
        <contact_address>6th Floor- Central building of TUMS- Qods St- Keshavarz Blvd Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
